"Dyskinesia, Drug-Induced" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Descriptor ID |
D004409
|
| MeSH Number(s) |
C10.228.662.262.500 C10.597.350.275 C10.720.312 C23.888.592.350.275 C25.100.750 C25.723.705.200
|
| Concept/Terms |
Dyskinesia, Drug-Induced- Dyskinesia, Drug-Induced
- Drug-Induced Dyskinesia
- Drug-Induced Dyskinesias
- Dyskinesia, Drug Induced
- Dyskinesias, Drug-Induced
Dyskinesia, Medication-Induced- Dyskinesia, Medication-Induced
- Dyskinesia, Medication Induced
- Dyskinesias, Medication-Induced
- Medication-Induced Dyskinesias
- Medication-Induced Dyskinesia
- Medication Induced Dyskinesia
|
Below are MeSH descriptors whose meaning is more general than "Dyskinesia, Drug-Induced".
Below are MeSH descriptors whose meaning is more specific than "Dyskinesia, Drug-Induced".
This graph shows the total number of publications written about "Dyskinesia, Drug-Induced" by people in this website by year, and whether "Dyskinesia, Drug-Induced" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dyskinesia, Drug-Induced" by people in Profiles.
-
D1 and D2 dopamine receptors differentially mediate the activation of phosphoproteins in the striatum of amphetamine-sensitized rats. Psychopharmacology (Berl). 2011 Apr; 214(3):653-63.
-
Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments. Mov Disord. 2008 Jul 30; 23(10):1479-82.
-
Psychosis in elderly patients: classification and pharmacotherapy. J Geriatr Psychiatry Neurol. 2003 Dec; 16(4):199-206.
-
Decreased pallidal GABA following reverse microdialysis with clozapine, but not haloperidol. Neuroreport. 2001 Dec 04; 12(17):3655-8.
-
Chronic haloperidol-induced alterations in pallidal GABA and striatal D(1)-mediated dopamine turnover as measured by dual probe microdialysis in rats. Neuroscience. 2000; 100(3):507-14.
-
Emergence of oral and locomotor activity in chronic haloperidol-treated rats following cortical N-methyl-D-aspartate stimulation. Pharmacol Biochem Behav. 1998 May; 60(1):167-73.
-
Measurement of the validity of utility elicitations performed by computerized interview. Med Care. 1997 Sep; 35(9):915-20.
-
Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia. Neuropsychopharmacology. 1993 Sep; 9(2):101-9.
-
Possible clozapine exacerbation of bulimia nervosa. Am J Psychiatry. 1992 Oct; 149(10):1408-9.
-
The effect of benztropine on haloperidol-induced dystonia, clinical efficacy and pharmacokinetics: a prospective, double-blind trial. J Clin Psychopharmacol. 1991 Apr; 11(2):106-12.